Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Lis William Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 Lis William (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 18,903 shares @ $26.45, valued at $500k
06/08/2023 4 Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/07/2023 4 Lis William (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Sold 5,434 shares @ $38.31, valued at $208.2k
10/13/2022 4 Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 29,500 shares @ $0
06/28/2022 4 Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Sold 24,743 shares @ $2.022, valued at $50k
Sold 24,743 shares @ $2.0775, valued at $51.4k
03/23/2022 4 Lis William (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 89,972 shares @ $0
Granted 7,500 options to buy @ $3.54, valued at $26.6k
Granted 89,972 options to buy @ $3.54, valued at $318.5k
Granted 100,000 options to buy @ $3.54, valued at $354k
01/21/2022 4 Lis William (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Sold 1,926 shares @ $53.4, valued at $102.8k
01/04/2022 4 Lis William (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 7,763 shares @ $0
01/28/2021 4 Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Disposed/sold 21,528 options to buy @ $48.51, valued at $1M
Disposed/sold 21,528 options to buy @ $30.87, valued at $664.6k
Disposed/sold 43,056 options to buy @ $13.67, valued at $588.6k
01/20/2021 4 Lis William (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 3,852 shares @ $0
05/29/2020 4 Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 21,528 options to buy @ $48.51, valued at $1M
06/13/2019 4 Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 21,528 options to buy @ $30.87, valued at $664.6k
12/07/2018 4 Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 43,056 options to buy @ $13.67, valued at $588.6k
08/28/2018 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Exercised 35,000 shares @ $0
Paid exercise price by delivering 17,587 shares @ $26.05, valued at $458.1k
06/08/2018 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Sold 5,113 shares @ $45.21, valued at $231.2k
05/24/2018 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 12,890 shares @ $0
Paid exercise price by delivering 6,491 shares @ $40.82, valued at $265k
03/06/2018 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 19,184 shares @ $32.53, valued at $624.1k
02/02/2018 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 25,000 shares @ $0
Granted 100,000 options to buy @ $51.31, valued at $5.1M
08/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/11/2017 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Sold 6,750 shares @ $36.06, valued at $243.4k
03/03/2017 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 13,669 shares @ $38.61, valued at $527.8k
02/01/2017 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 34,375 shares @ $0
Granted 137,500 options to buy @ $25.54, valued at $3.5M
Granted 34,375 rights @ $0
05/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/04/2016 4 Lis William (CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 3,492 shares @ $31.75, valued at $110.9k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy